Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
Matthews Asia's Sean Taylor explains why he remains constructive on China despite the broader indexes lagging some high-performing sectors. He also outlines his South Korea strategy, including an ...
How to make big, well, some bucks in late night? According to CBS, the trick is to cancel your traditional show and lease the time to someone else. The Paramount Skydance broadcast outlet, which has ...
Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...
“Celebrate Me,” a TikTok-viral song that was created with the AI music generator Suno, is No. 1 on the iTunes chart in the United States and several other countries as the AI music generator grows in ...
The Anker SOLIX C1000 Gen 2 is down to $699.98 in a limited-time deal, a $898 saving off its $1,598 list price, and this isn’t just the power station on its own. The 200W bifacial solar panel is ...
An ongoing and heated dispute between the Pentagon and Anthropic is raising new questions about how the startup’s technology is actually used inside the US military. In late February, Anthropic ...
Use left and right arrow keys to seek audio. Microsoft's Jason Ronald reveals new details about the next-gen Project Helix console at GDC 2026, as per a recent live stream. Microsoft confirming key ...
Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...
Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results